Modulation of various host cellular machinery during COVID‐19 infection
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Modulation of various host cellular machinery during COVID‐19 infection
Authors
Keywords
-
Journal
REVIEWS IN MEDICAL VIROLOGY
Volume 33, Issue 6, Pages -
Publisher
Wiley
Online
2023-09-28
DOI
10.1002/rmv.2481
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SARS-CoV-2 viral protein Nsp2 stimulates translation under normal and hypoxic conditions
- (2023) Nadejda Korneeva et al. Virology Journal
- The SARS-CoV-2 UTR’s Intrudes Host RBP’s and Modulates Cellular Splicing
- (2023) Anjali Singh et al. Advances in Virology
- BRD2 inhibition blocks SARS-CoV-2 infection by reducing transcription of the host cell receptor ACE2
- (2022) Avi J. Samelson et al. NATURE CELL BIOLOGY
- Targeting stem-loop 1 of the SARS-CoV-2 5′ UTR to suppress viral translation and Nsp1 evasion
- (2022) Setu M. Vora et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- N7-Methylation of the Coronavirus RNA Cap Is Required for Maximal Virulence by Preventing Innate Immune Recognition
- (2022) Ruangang Pan et al. mBio
- ACE2 is the critical in vivo receptor for SARS-CoV-2 in a novel COVID-19 mouse model with TNF- and IFNγ-driven immunopathology
- (2022) Riem Gawish et al. eLife
- The key features of SARS-CoV-2 leader and NSP1 required for viral escape of NSP1-mediated repression
- (2022) Lucija Bujanic et al. RNA
- Abnormal global alternative RNA splicing in COVID-19 patients
- (2022) Changli Wang et al. PLoS Genetics
- Drug targeting Nsp1-ribosomal complex shows antiviral activity against SARS-CoV-2
- (2022) Mohammad Afsar et al. eLife
- Kinase Inhibitors as Potential Therapeutic Agents in the Treatment of COVID-19
- (2022) Rajashri R. Naik et al. Frontiers in Pharmacology
- Long-Read RNA Sequencing Identifies Polyadenylation Elongation and Differential Transcript Usage of Host Transcripts During SARS-CoV-2 In Vitro Infection
- (2022) Jessie J.-Y. Chang et al. Frontiers in Immunology
- Translational Control of COVID-19 and Its Therapeutic Implication
- (2022) Dejiu Zhang et al. Frontiers in Immunology
- Comparative Analysis of Long Non-Coding RNA Expression and Immune Response in Mild and Severe COVID-19
- (2022) Yongting Zhang et al. Frontiers in Molecular Biosciences
- Sulforaphane exhibits antiviral activity against pandemic SARS-CoV-2 and seasonal HCoV-OC43 coronaviruses in vitro and in mice
- (2022) Alvaro A. Ordonez et al. Communications Biology
- COVID-19: Challenges of Viral Variants
- (2022) Jana L. Jacobs et al. Annual Review of Medicine
- The mechanism of RNA capping by SARS-CoV-2
- (2022) Gina J. Park et al. NATURE
- The Role of Viral RNA Degrading Factors in Shutoff of Host Gene Expression
- (2022) Léa Gaucherand et al. Annual Review of Virology
- Pathophysiological involvement of host mitochondria in SARS-CoV-2 infection that causes COVID-19: a comprehensive evidential insight
- (2022) Chandan Bhowal et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Host protein kinases required for SARS-CoV-2 nucleocapsid phosphorylation and viral replication
- (2022) Tomer M. Yaron et al. Science Signaling
- Transcription factor Nrf2 as a potential therapeutic target for COVID-19
- (2022) Yifan Wang et al. CELL STRESS & CHAPERONES
- Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults
- (2021) Romina Libster et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dynamic competition between SARS-CoV-2 NSP1 and mRNA on the human ribosome inhibits translation initiation
- (2021) Christopher P. Lapointe et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- COVID-19: Immunology, Immunopathogenesis and Potential Therapies
- (2021) Asha Bhardwaj et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- An immune epigenetic insight to COVID-19 infection
- (2021) Bimal P Jit et al. Epigenomics
- Inhibition of anti-viral stress granule formation by coronavirus endoribonuclease nsp15 ensures efficient virus replication
- (2021) Bo Gao et al. PLoS Pathogens
- The SARS‐unique domain (SUD) of SARS‐CoV and SARS‐CoV‐2 interacts with human Paip1 to enhance viral RNA translation
- (2021) Jian Lei et al. EMBO JOURNAL
- Interplay between SARS‐CoV‐2 and human long non‐coding RNAs
- (2021) Maryam Moazzam‐Jazi et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- SARS-CoV-2 uses a multipronged strategy to impede host protein synthesis
- (2021) Yaara Finkel et al. NATURE
- The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates
- (2021) Bryan E. Jones et al. Science Translational Medicine
- Critical Involvement of TFIIB in Viral Pathogenesis
- (2021) Michael J. O’Brien et al. Frontiers in Molecular Biosciences
- Bromodomain and Extraterminal Protein Inhibitor, Apabetalone (RVX-208), Reduces ACE2 Expression and Attenuates SARS-Cov-2 Infection In Vitro
- (2021) Dean Gilham et al. Biomedicines
- Identification and evaluation of potential SARS-CoV-2 antiviral agents targeting mRNA cap guanine N7-Methyltransferase
- (2021) Renata Kasprzyk et al. ANTIVIRAL RESEARCH
- SARS-CoV-2: Understanding the Transcriptional Regulation of ACE2 and TMPRSS2 and the Role of Single Nucleotide Polymorphism (SNP) at Codon 72 of p53 in the Innate Immune Response against Virus Infection
- (2021) Niraj Lodhi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities
- (2021) Myron S. Cohen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Multi-level inhibition of coronavirus replication by chemical ER stress
- (2021) Mohammed Samer Shaban et al. Nature Communications
- The Functions of BET Proteins in Gene Transcription of Biology and Diseases
- (2021) Ka Lung Cheung et al. Frontiers in Molecular Biosciences
- A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data
- (2021) Karin Welén et al. EUROPEAN UROLOGY
- Nrf2 activator PB125® as a carnosic acid-based therapeutic agent against respiratory viral diseases, including COVID-19
- (2021) Joe M. McCord et al. FREE RADICAL BIOLOGY AND MEDICINE
- Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab
- (2021) Anil Gupta et al. NEW ENGLAND JOURNAL OF MEDICINE
- The SARS-CoV-2 RNA polymerase is a viral RNA capping enzyme
- (2021) Alexander P Walker et al. NUCLEIC ACIDS RESEARCH
- SARS-CoV-2 expresses a microRNA-like small RNA able to selectively repress host genes
- (2021) Paulina Pawlica et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting conserved N-glycosylation blocks SARS-CoV-2 variant infection in vitro
- (2021) Hsiang-Chi Huang et al. EBioMedicine
- SARS-CoV-2 nucleocapsid protein binds host mRNAs and attenuates stress granules to impair host stress response
- (2021) Syed Nabeel-Shah et al. iScience
- Telmisartan as tentative angiotensin receptor blocker therapeutic for COVID ‐19
- (2020) Rodolfo Pedro Rothlin et al. DRUG DEVELOPMENT RESEARCH
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
- (2020) Yeming Wang et al. LANCET
- A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
- (2020) David E. Gordon et al. NATURE
- A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV
- (2020) Meng Yuan et al. SCIENCE
- The Human Coronavirus Disease COVID-19: Its Origin, Characteristics, and Insights into Potential Drugs and Its Mechanisms
- (2020) Lo’ai Alanagreh et al. Pathogens
- The Global Phosphorylation Landscape of SARS-CoV-2 Infection
- (2020) Mehdi Bouhaddou et al. CELL
- COVID-19, SARS and MERS: are they closely related?
- (2020) N. Petrosillo et al. CLINICAL MICROBIOLOGY AND INFECTION
- Putative Roles for Peptidylarginine Deiminases in COVID-19
- (2020) Elif Damla Arisan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- ACE2 Expression Is Increased in the Lungs of Patients With Comorbidities Associated With Severe COVID-19
- (2020) Bruna G G Pinto et al. JOURNAL OF INFECTIOUS DISEASES
- p38 MAPK inhibition: A promising therapeutic approach for COVID-19
- (2020) Joseph M. Grimes et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Repurposing the mucolytic cough suppressant and TMPRSS2 protease inhibitor bromhexine for the prevention and management of SARS-CoV-2 infection
- (2020) Roberto Maggio et al. PHARMACOLOGICAL RESEARCH
- Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies
- (2020) Alina Baum et al. SCIENCE
- Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2
- (2020) Matthias Thoms et al. SCIENCE
- Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail
- (2020) Johanna Hansen et al. SCIENCE
- Clinical efficacy of antivirals against novel coronavirus (COVID-19): A review
- (2020) Shahamah Jomah et al. Journal of Infection and Public Health
- Histone Demethylase KDM5B as a Therapeutic Target for Cancer Therapy
- (2020) Anmi Jose et al. Cancers
- Neutrophil extracellular traps in COVID-19
- (2020) Yu Zuo et al. JCI Insight
- Flavonoids Activation of the Transcription Factor Nrf2 as a Hypothesis Approach for the Prevention and Modulation of SARS-CoV-2 Infection Severity
- (2020) Patricia Mendonca et al. Antioxidants
- Mutations in the phosphorylation sites of SARS-CoV-2 encoded nucleocapsid protein and structure model of sequestration by protein 14-3-3
- (2020) H.Y. Lim Tung et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses
- (2020) Abhik K. Banerjee et al. CELL
- A comparative analysis of remdesivir and other repurposed antivirals against SARS‐CoV‐2
- (2020) Alexander Simonis et al. EMBO Molecular Medicine
- SARS-CoV-2–triggered neutrophil extracellular traps mediate COVID-19 pathology
- (2020) Flavio Protasio Veras et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Pathophysiology and treatment strategies for COVID-19
- (2020) Manoj Kumar et al. Journal of Translational Medicine
- SARS-CoV-2 vaccines in development
- (2020) Florian Krammer NATURE
- SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation
- (2020) Katharina Schubert et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate
- (2020) David Olagnier et al. Nature Communications
- The epigenetic implication in coronavirus infection and therapy
- (2020) Sandra Atlante et al. Clinical Epigenetics
- Identification of Novel SARS-CoV-2 Drug Targets by Host MicroRNAs and Transcription Factors Co-regulatory Interaction Network Analysis
- (2020) Rahila Sardar et al. Frontiers in Genetics
- Unravelling host-pathogen interactions: ceRNA network in SARS-CoV-2 infection (COVID-19)
- (2020) Shweta Arora et al. GENE
- Role of Host-Mediated Post-Translational Modifications (PTMs) in RNA Virus Pathogenesis
- (2020) Ramesh Kumar et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Nonstructural Protein 1 of SARS-CoV-2 Is a Potent Pathogenicity Factor Redirecting Host Protein Synthesis Machinery toward Viral RNA
- (2020) Shuai Yuan et al. MOLECULAR CELL
- Translational control of coronaviruses
- (2020) Sylvain de Breyne et al. NUCLEIC ACIDS RESEARCH
- Viral-induced alternative splicing of host genes promotes influenza replication
- (2020) Matthew G Thompson et al. eLife
- Interplay between Influenza Virus and the Host RNA Polymerase II Transcriptional Machinery
- (2019) Alexander P. Walker et al. TRENDS IN MICROBIOLOGY
- A yeast suppressor screen used to identify mammalian SIRT1 as a proviral factor for MERS-CoV replication
- (2019) Stuart Weston et al. JOURNAL OF VIROLOGY
- Viral modulation of cellular RNA alternative splicing: A new key player in virus–host interactions?
- (2019) Simon Boudreault et al. Wiley Interdisciplinary Reviews-RNA
- Host Shutoff in Influenza A Virus: Many Means to an End
- (2018) Rachel Levene et al. Viruses-Basel
- The Functional Role of the 3′ Untranslated Region and Poly(A) Tail of Duck Hepatitis A Virus Type 1 in Viral Replication and Regulation of IRES-Mediated Translation
- (2018) Jun-Hao Chen et al. Frontiers in Microbiology
- Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses
- (2016) Shuo Su et al. TRENDS IN MICROBIOLOGY
- Genomic Analysis of 15 Human Coronaviruses OC43 (HCoV-OC43s) Circulating in France from 2001 to 2013 Reveals a High Intra-Specific Diversity with New Recombinant Genotypes
- (2015) Nathalie Kin et al. Viruses-Basel
- Nucleocapsid Phosphorylation and RNA Helicase DDX1 Recruitment Enables Coronavirus Transition from Discontinuous to Continuous Transcription
- (2014) Chia-Hsin Wu et al. Cell Host & Microbe
- Influenza Viruses and mRNA Splicing: Doing More with Less
- (2014) J. Dubois et al. mBio
- Sirtuins Are Evolutionarily Conserved Viral Restriction Factors
- (2014) Emre Koyuncu et al. mBio
- Epigenetic regulation of angiotensin-converting enzyme 2 (ACE2) by SIRT1 under conditions of cell energy stress
- (2013) Nicola E. Clarke et al. CLINICAL SCIENCE
- Regulation of Coronaviral Poly(A) Tail Length during Infection
- (2013) Hung-Yi Wu et al. PLoS One
- Conventional and unconventional mechanisms for capping viral mRNA
- (2011) Etienne Decroly et al. NATURE REVIEWS MICROBIOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started